{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:41:12Z","timestamp":1792406472856,"version":"4.4.0"},"reference-count":26,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Stroke is a severe complication associated with sickle cell disease (SCD). The risk of recurrence is extremely high. The present study aimed to assess the clinical and biological efficacy of Partial Red Cell Exchange (PRE) in secondary stroke prevention among a cohort of Tunisian patients with SCD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>We conducted a prospective study over a 15\u2010year period (January 1, 2010\u2014December 31, 2024). A total of 29 patients with sickle cell syndromes complicated by one or more strokes were enrolled. They underwent 1732 PRE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age was 99\u2009months (75\u2013133). The median follow\u2010up duration was 78\u2009months (49\u2013126). The mean HbS decreased from 40.1%\u2009\u00b1\u200914.1% to 21.1%\u2009\u00b1\u200911.1% post\u2010exchange (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Treatment failure was observed in 8 of 29 patients (27.5%), with a total of 12 neurological events over a cumulative treatment duration of 1570\u2009months. 11 of 12 recurrences (91.7%) occurred within the first 4\u2009years of the exchange program. The presence of moyamoya vasculopathy was predictive of therapeutic failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PRE remains an effective modality for secondary stroke prevention in patients with sickle cell disease. Stroke recurrences occur predominantly within the first 4\u2009years of treatment and are more frequent in the context of severe cerebrovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ejh.70338","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:49:50Z","timestamp":1792403390000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Partial Red Cell Exchange in the Secondary Prevention of Stroke in Sickle Cell Disease: A Prospective Study"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8369-3655","authenticated-orcid":false,"given":"Mellouli","family":"Fethi","sequence":"first","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"},{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouzidi","family":"Leyla","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksouri","family":"Habib","sequence":"additional","affiliation":[{"name":"Department of Laboratories National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2275-0896","authenticated-orcid":false,"given":"Ben Fraj","family":"Ilhem","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"},{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6356-2673","authenticated-orcid":false,"given":"Rekaya","family":"Samya","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"},{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-7515","authenticated-orcid":false,"given":"Ben Khaled","family":"Monia","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"},{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Ridha","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouari","family":"Bechir","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"},{"name":"Service de m\u00e9decine Communautaire Facult\u00e9 de m\u00e9decine de Tunis  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouederni","family":"Monia","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"},{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bejaoui","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immuno\u2010Hematology National Bone Marrow Transplant Center of Tunis  Tunis Tunisia"},{"name":"Facult\u00e9 de m\u00e9decine de Tunis Universit\u00e9 Tunis El Manar  Tunis Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"1","key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of Transfusion Therapy on Arteriographic Abnormalities and on Recurrences of Stroke in Sickle Cell Disease","volume":"63","author":"Russell M. O.","year":"1984","journal-title":"Blood"},{"issue":"6","key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risck of Recurrent Stroke in Patients With Sickle Cell Disease Treated With Erythrocyte Transfusions","volume":"126","author":"Pegelow C. H.","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(97)70108-2","article-title":"Discontinuation of Long\u2010Term Transfusion Therapy in Patients With Sickle Cell Disease and Stroke","volume":"131","author":"Rana S.","year":"1997","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High Risk of Recurrent Stroke After Discontinuance of Five to Twelve Years of Transfusion Therapy in Patients With Sickle Cell Disease","volume":"118","author":"Wang W. C.","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The Natural History of Stroke in Sickle Cell Disease","volume":"65","author":"Powars D.","year":"1978","journal-title":"American Journal of Medicine"},{"issue":"1","key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a First Stroke by Transfusions in Children With Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography","volume":"339","author":"Adams R. J.","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease","volume":"353","author":"Adams R. J.","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(83)80716-1","article-title":"Recurrent Cerebral Ischemia During Hypertransfusion Therapy in Sickle Cell Anemia","volume":"103","author":"Buchanan G. R.","year":"1983","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"e_1_2_11_10_1","first-page":"288","article-title":"Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors","volume":"91","author":"Ohene\u2010Frempong K.","year":"1998","journal-title":"Blood"},{"issue":"9","key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya Syndrome in Childhood Sickle Cell Disease: A Predictive Factor for Recurrent Cerebrovascular Events","volume":"99","author":"Dobson S. R.","year":"2002","journal-title":"Blood"},{"issue":"6","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.arcped.2012.03.014","article-title":"Int\u00e9r\u00eat et difficult\u00e9s de l'\u00e9rythraph\u00e9r\u00e8se chez les patients dr\u00e9panocytaires: \u00e0 propos d'une exp\u00e9rience p\u00e9diatrique","volume":"19","author":"Filhon B.","year":"2012","journal-title":"Archives de P\u00e9diatrie"},{"issue":"4","key":"e_1_2_11_13_1","first-page":"232\u015441","article-title":"Results of Partial Transfusion Exchange in 42 Homozygous Sickle Cell Patients at University Hospital of Brazzaville","volume":"17","author":"Dokekias A. E.","year":"2010","journal-title":"Transfusion Clinique et Biologique"},{"issue":"3","key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.transci.2005.03.003","article-title":"Chronic Red Blood Cell Exchange to Prevent Clinical Complications in Sickle Cell Disease","volume":"32","author":"Cabibbo S.","year":"2005","journal-title":"Transfusion and Apheresis Science"},{"issue":"3","key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.transci.2007.09.005","article-title":"Periodic Erythroexchange Is an Effective Strategy for High Risk Paediatric Patients With Sickle Cell Disease","volume":"37","author":"Masera N.","year":"2007","journal-title":"Transfusion and Apheresis Science"},{"issue":"4","key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V83.4.1136.1136","article-title":"Erythrocytapheresis Therapy to Reduce Iron Overload in Chronically Transfused Patients With Sickle Cell Disease","volume":"83","author":"Kim H. C.","year":"1994","journal-title":"Blood"},{"issue":"3","key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2005-10-009506","article-title":"Stroke Prevention Trial in Sickle Cell Anemia (STOP): Extended Follow\u2010Up and Final Results","volume":"108","author":"Lee M. T.","year":"2006","journal-title":"Blood"},{"key":"e_1_2_11_18_1","volume-title":"Syndromes dr\u00e9panocytaires majeurs de l'enfant et de l'adolescent: Protocole national de diagnostic et de soins pour une maladie rare","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2010"},{"key":"e_1_2_11_19_1","volume-title":"Blood Transfusion for Pediatric Patients With Sickle Cell Disease","author":"New England Pediatric Sickle Cell Consortium","year":"2003"},{"key":"e_1_2_11_20_1","volume-title":"The Management of Sickle Cell Disease","author":"National Institutes of Health: Divison of blood diseases and resources","year":"2002"},{"issue":"9","key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","article-title":"Management of Stroke in Infants and Children","volume":"39","author":"Roach E. S.","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"e_1_2_11_22_1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1542\/peds.2010-1791","article-title":"Quality of Care Indicators for Children With Sickle Cell Disease","volume":"128","author":"Wang C. J.","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the Patient With Sickle Cell Disease: A Critical Review of the Literature and Transfusion Guidelines","volume":"21","author":"Josephson C. D.","year":"2007","journal-title":"Transfusion Medicine Reviews"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/524513","article-title":"Transfusion Practices in the Management of Sickle Cell Disease: A Survey of Florida Hematologists\/Oncologists","volume":"2012","author":"Dunbar L. N.","year":"2012","journal-title":"ISRN Hematology"},{"issue":"2","key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 Guidelines for Sickle Cell Disease: Transfusion Support","volume":"4","author":"Chou S. T.","year":"2020","journal-title":"Blood Advances"},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.14383","article-title":"Guidelines on Red Cell Transfusion in Sickle Cell Disease Part II: Indications for Transfusion","volume":"176","author":"Bernard A. D.","year":"2017","journal-title":"British Journal of Haematology"},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jca.22078","article-title":"HemoglobinS Target of <50% as Compared to 30% in Chronic Redcell Exchange for Secondary Stroke Prevention in Sickle Cell Disease","volume":"38","author":"Choi J.","year":"2023","journal-title":"Journal of Clinical Apheresis"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ejh.70338","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:49:54Z","timestamp":1792403394000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.70338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":26,"alternative-id":["10.1111\/ejh.70338"],"URL":"https:\/\/doi.org\/10.1111\/ejh.70338","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"2025-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ejh.70338"}}